SESEN BIO INC (SESN)
US8177631053 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 71.11M | 162.64M | 52.40M | 48.10M | 50.40M | |||
| Marketable Securities | 106.43M | N/A | N/A | N/A | N/A | |||
| Receivables | 14.30M | 24.49M | N/A | N/A | N/A | |||
| Other Current Assets | 527.00K | 18.48M | 10.50M | 6.30M | 1.30M | |||
| Total Current Assets | 192.36M | 205.60M | 62.90M | 54.40M | 51.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 43.00K | 100.00K | 200.00K | 300.00K | |||
| Investments And Advances | 7.34M | N/A | N/A | N/A | N/A | |||
| Goodwill | 0.00 | 13.06M | 13.10M | 13.10M | 13.10M | |||
| Intangibles | 0.00 | 14.70M | 46.40M | 46.40M | 46.40M | |||
| Other Non-Current Assets | 30.00K | 7.33M | 400.00K | 200.00K | 0.00 | |||
| Total Non-Current Assets | 7.37M | 35.14M | 59.90M | 60.00M | 59.80M | |||
| TOTAL ASSETS | 199.72M | 240.75M | 122.80M | 114.40M | 111.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 33.75M | 8.37M | 4.20M | 6.20M | 4.70M | |||
| Accounts Payable | 514.00K | 2.85M | 3.10M | 1.90M | 1.40M | |||
| Other Current Liabilities | 430.00K | 345.00K | 10.70M | 400.00K | N/A | |||
| Total Current Liabilities | 34.70M | 11.57M | 18.00M | 8.50M | 6.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 0.00 | 3.97M | 12.50M | 12.50M | 12.50M | |||
| Other Non-Current Liabilities | 0.00 | 53.50M | 101.50M | 120.00M | 48.70M | |||
| Total Non-Current Liabilities | 0.00 | 57.47M | 114.10M | 132.60M | 61.30M | |||
| TOTAL LIABILITIES | 34.70M | 69.04M | 132.10M | 141.10M | 67.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -328.57M | -316.26M | -315.90M | -293.50M | -186.00M | |||
| Additional Paid In Capital | 493.63M | 487.77M | 306.60M | 266.70M | 230.20M | |||
| Common Shares | 202.00K | 199.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -235.00K | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 202.76M | 199.46M | 140.40M | 106.80M | 77.50M | |||
| Tangible Book Value per Share | 0.81 | 0.72 | -0.49 | -0.81 | -0.20 | |||
| Total Shareholders' Equity | 165.03M | 171.71M | -9.20M | -26.70M | 44.20M | |||
| TOTAL LIABILITIES AND EQUITY | 199.72M | 240.75M | 122.80M | 114.40M | 111.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 5.54 | 17.77 | 3.49 | 6.40 | 8.49 | |||
| Return On Assets (ROA) | -2.09% | -0.14% | -18.36% | -93.97% | -30.19% | |||
| Return On Equity (ROE) | -2.53% | -0.20% | N/A | N/A | -76.22% | |||
| Return On Invested Capital (ROIC) | 14.26% | 9.89% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 34.05% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | 58.42% | N/A | N/A | N/A | |||
All data in USD